Replies to post #747054 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

I understand thats a good strategy as well

[exwannabe]

I’m going to wait at least for the announcement of the Combination therapy trials. After the third announcement, the market will wake up. At that time I might sell 10%.

I am sure one more announcement of plans to launch combo trials will be huge.

Does anybody recall how the price reacted back in 2016?

The Company has reached conceptual agreement with three different sets of parties, in regard to three different combination treatments, for three different cancers in three different Phase II trials. These involve leading participants in the immunotherapy field. The Company and these parties are now completing the agreements and budgets, and pursuing regulatory approval for the agreed upon trials.

And:a few months later:

BETHESDA, MD, November 17, 2016 – Northwest Biotherapeutics (NASDAQ: NWBO) (“NW Bio”), a U.S. biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today joined the University Medical Center (UMC) of the Johannes Gutenberg University Mainz in Germany in announcing a Phase II clinical trial program combining DCVax®-L and Pembrolizumab (Keytruda®) for colorectal cancer with liver metastases.

I am sure most investors have forgotten the numerous carrots laid out for investors and will bite again this time,

[Investor082]

Thank you. We need more bag holders such as you, so some of us can sell on UK approval PR and have as little competition as possible. Some will sell 100%, others will sell 80-90%, but we also need bag holders who don’t sell so we can exit at a good valuation.